In the BioHarmony Drug Report Database

"Preview" Icon

Desoximetasone

Topicort, Topicort Lp, Neofordex, Ozurdex (desoximetasone) is a small molecule pharmaceutical. Desoximetasone was first approved as Topicort on 1982-01-01. It is used to treat facial dermatoses, foot dermatoses, hand dermatoses, inflammation, and leg dermatoses amongst others in the USA. It has been approved in Europe to treat macular edema, multiple myeloma, and uveitis. The pharmaceutical is active against glucocorticoid receptor. Topicort’s patent is valid until 2028-09-01 (FDA).

 

Trade Name

 

Neofordex, Ozurdex
 

Common Name

 

desoximetasone
 

ChEMBL ID

 

CHEMBL1766
 

Indication

 

facial dermatoses, foot dermatoses, hand dermatoses, inflammation, leg dermatoses, macular edema, multiple myeloma, scalp dermatoses, uveitis
 

Drug Class

 

Image (chem structure or protein)

Desoximetasone structure rendering